
zzso results from most late-stage clinical trials of cancer zzso indicate a need for improved and zzso animal tumor zzso This zzso of models, combined with the advent of a class of drugs that target the tumor zzso rather than the tumor cell, presents new challenges for designing and interpreting zzso efficacy zzso A comparison of the clinical efficacy of zzso drugs with their corresponding zzso studies over the past two decades offers many lessons that can inform and improve the design of experiments in existing mouse zzso In addition, technological and logistical advances in mouse models of human cancer over the past five years have the potential to increase the clinical zzso of animal zzso 

